Published in J Pediatr on February 01, 1991
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood (1993) 2.29
WHIM syndrome: congenital immune deficiency disease. Curr Opin Hematol (2009) 1.85
AMD3100 is a potent antagonist at CXCR4(R334X) , a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome. J Cell Mol Med (2011) 1.14
Warts and all: human papillomavirus in primary immunodeficiencies. J Allergy Clin Immunol (2012) 1.06
Infections in patients with inherited defects in phagocytic function. Clin Microbiol Rev (2003) 1.02
Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry. Orphanet J Rare Dis (2012) 1.01
Genetics on a WHIM. Br J Haematol (2013) 0.82
A report of WHIM syndrome (myelokathexis) - clinical features and bone marrow morphology. Rev Bras Hematol Hemoter (2011) 0.78
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol (2000) 9.76
Antigens on human monocytes identified by monoclonal antibodies. J Immunol (1981) 4.67
Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science (1998) 4.24
Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science (1991) 3.96
Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood (2000) 3.45
Growth-related changes in phosphorylation of yeast RNA polymerase II. J Biol Chem (1998) 3.24
Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol). J Clin Invest (1983) 3.23
Subcellular localization of the large subunit of Mo1 (Mo1 alpha; formerly gp 110), a surface glycoprotein associated with neutrophil adhesion. J Clin Invest (1984) 3.01
Structural analysis of differentiation antigens Mo1 and Mo2 on human monocytes. Hybridoma (1982) 2.92
The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes. Blood (1976) 2.76
Deficiency of a leukocyte surface glycoprotein (LFA-1) in two patients with Mo1 deficiency. Effects of cell activation on Mo1/LFA-1 surface expression in normal and deficient leukocytes. J Clin Invest (1984) 2.46
Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest (1988) 2.46
Two functional domains in the phagocyte membrane glycoprotein Mo1 identified with monoclonal antibodies. J Immunol (1986) 2.45
Neutrophil action dysfunction and abnormal neutrophil behavior. N Engl J Med (1974) 2.35
Deficiency of a surface membrane glycoprotein (Mo1) in man. J Clin Invest (1984) 2.29
Immunologic classification of leukemia and lymphoma. Blood (1986) 2.28
Autooxidation as a basis for altered function by polymorphonuclear leukocytes. Blood (1977) 2.10
Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem (1993) 2.02
Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun (1991) 1.99
Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an RNA polymerase II-associated cyclin. Neuron (2001) 1.93
The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest (1994) 1.82
A T-lymphoma transmembrane glycoprotein (gp180) is linked to the cytoskeletal protein, fodrin. J Cell Biol (1985) 1.80
Hemicrania continua: diagnostic criteria and nosologic status. Cephalalgia (2001) 1.72
Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med (1989) 1.67
Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res (1994) 1.64
Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J Clin Invest (1988) 1.63
Arterial stiffness is associated with left atrial size in hypertensive patients. Arch Cardiovasc Dis (2008) 1.58
Lactoferrin: a promoter of polymorphonuclear leukocyte adhesiveness. Blood (1981) 1.57
Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med (1985) 1.55
Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood (2000) 1.54
Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate. N Engl J Med (1976) 1.52
Analysis of antigenic determinants on human monocytes and macrophages. Blood (1982) 1.50
Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest (1993) 1.49
Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res (1997) 1.49
Persistence of isolated flow in the internal carotid artery in brain death. J Neurol Sci (2003) 1.49
Heat-shock induced proteins present in the cell nucleus of Chironomus tentans salivary gland. Nature (1979) 1.48
The hemicrania continua diagnosis. Cephalalgia (2001) 1.48
Docetaxel for patients with paclitaxel-resistant Müllerian carcinoma. J Clin Oncol (2000) 1.46
Conservation of myeloid surface antigens on primate granulocytes. Blood (1983) 1.44
Role of beta 1, beta 2 integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes. J Immunol (1993) 1.44
[The role of polarised light in the examination of specimens from patients with sarcoidosis]. Rev Mal Respir (2006) 1.39
The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest (1996) 1.38
Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J Clin Oncol (2001) 1.37
Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial. J Clin Oncol (2000) 1.37
Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. J Immunol (1994) 1.37
Rapid induction of neutrophil-endothelial adhesion by endothelial complement fixation. Nature (1989) 1.37
The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res (1994) 1.36
Cryptogenic fibrosing alveolitis and Epstein-Barr virus: an association? Lancet (1984) 1.35
The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer (2001) 1.35
Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet (1986) 1.34
Modulation and function of intercellular adhesion molecule-1 (CD54) on human retinal pigment epithelial cells. Lab Invest (1992) 1.33
Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. J Clin Oncol (1989) 1.32
Interactions of actin, myosin, and an actin-binding protein of chronic myelogenous leukemia leukocytes. J Clin Invest (1976) 1.31
Roles of beta 2 integrins of rat neutrophils in complement- and oxygen radical-mediated acute inflammatory injury. J Immunol (1992) 1.30
Effects of a chemotactic factor, N-formylmethionyl peptide, on adherence, superoxide anion generation, phagocytosis, and microtubule assembly of human polymorphonuclear leukocytes. J Lab Clin Med (1979) 1.30
Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. J Immunol (1994) 1.29
Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes. J Immunol (1998) 1.28
Clinical features and current management of chronic granulomatous disease. Hematol Oncol Clin North Am (1988) 1.28
The formation of ceramide-1-phosphate during neutrophil phagocytosis and its role in liposome fusion. J Biol Chem (1998) 1.27
Surface membrane heterogeneity among human mononuclear phagocytes. J Immunol (1984) 1.27
Integrins as promiscuous signal transduction devices. Immunol Today (1996) 1.27
Autonomic nervous system and cardiovascular variability in rats: a spectral analysis approach. Am J Physiol (1991) 1.27
Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells. Blood (2000) 1.26
Successful isolation of a rat chromosome 1 blood pressure quantitative trait locus in reciprocal congenic strains. Hypertension (1998) 1.26
Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fc gamma receptor IIIB and the complement receptor type 3. J Immunol (1994) 1.25
Unusual 1H NMR chemical shifts support (His) C(epsilon) 1...O==C H-bond: proposal for reaction-driven ring flip mechanism in serine protease catalysis. Proc Natl Acad Sci U S A (2000) 1.24
Urokinase receptor. An activation antigen in human T lymphocytes. J Immunol (1994) 1.24
Role of beta 2 integrins and ICAM-1 in lung injury following ischemia-reperfusion of rat hind limbs. Am J Pathol (1993) 1.24
Inhibition of polymorphonuclear leukocyte adherence by prostacyclin. J Lab Clin Med (1980) 1.24
B94, a primary response gene inducible by tumor necrosis factor-alpha, is expressed in developing hematopoietic tissues and the sperm acrosome. J Biol Chem (1994) 1.22
Nuclear translocation and carboxyl-terminal domain phosphorylation of RNA polymerase II delineate the two phases of zygotic gene activation in mammalian embryos. EMBO J (1997) 1.22
In vitro inhibition of granulopoiesis by 4-amino-4'-hydroxylaminodiphenyl sulfone. Br J Haematol (1980) 1.21
Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor. Blood (1982) 1.20
Thrombospondin stimulates motility of human neutrophils. J Cell Biol (1990) 1.20
Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies. Prog Hematol (1981) 1.19
Phagocytosis of neutrophils by marrow macrophages in childhood chronic benign neutropenia. J Pediatr (1981) 1.19
Lactoferrin deficiency associated with altered granulocyte function. N Engl J Med (1982) 1.17
Different intracellular distributions of heat-shock and arsenite-induced proteins in Drosophila Kc cells. Possible relation with the phosphorylation and translocation of a major cytoskeletal protein. J Mol Biol (1982) 1.17
Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann Neurol (1994) 1.17
Effect of alpha-2 glycoprotein on the immune response. Transplantation (1965) 1.17
Central cardiovascular effects of morphinomimetic peptides in dogs. Eur J Pharmacol (1977) 1.16
A cell surface marker for neural crest and placodal cells: further evolution in peripheral and central nervous system. Dev Biol (1984) 1.16
Primaty cutaneous histoplasmosis. Indian J Dermatol Venereol Leprol (2010) 1.16
Functions of human monocyte and lymphocyte subsets obtained by countercurrent centrifugal elutriation: differing functional capacities of human monocyte subsets. J Immunol (1981) 1.16
Supraorbital neuralgia. On the clinical manifestations and a possible therapeutic approach. Headache (1999) 1.16
The continuing saga of complement receptor type 3 (CR3) J Clin Invest (1996) 1.15
Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function. Circulation (1990) 1.15
Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF). J Immunol (1982) 1.15
The peptidyl-prolyl isomerase Pin1 interacts with hSpt5 phosphorylated by Cdk9. J Mol Biol (2001) 1.14
Neutrophil-induced injury of rat pulmonary alveolar epithelial cells. J Clin Invest (1986) 1.14
Role of leukocyte adhesion molecules in complement-induced lung injury. J Immunol (1993) 1.14
Association between gelatinase release and increased plasma membrane expression of the Mo1 glycoprotein. Blood (1987) 1.14
Insight into the conformational dynamics of specific regions of porcine pancreatic phospholipase A2 from a time-resolved fluorescence study of a genetically inserted single tryptophan residue. Biochemistry (1991) 1.14
Volume of the spleen in children as measured on CT scans: normal standards as a function of body weight. AJR Am J Roentgenol (1993) 1.13
Purified human plasma kallikrein aggregates human blood neutrophils. J Clin Invest (1982) 1.13
Diminished polymorphonuclear leukocyte adherence. Function dependent on release of cyclic AMP by endothelial cells after stimulation of beta-receptors by epinephrine. J Clin Invest (1980) 1.13